BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7685319)

  • 1. The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains.
    Martínez J; Campetella O; Frasch AC; Cazzulo JJ
    Immunol Lett; 1993 Feb; 35(2):191-6. PubMed ID: 7685319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.
    Martinez J; Campetella O; Frasch AC; Cazzulo JJ
    Infect Immun; 1991 Nov; 59(11):4275-7. PubMed ID: 1937786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exoantigens from trypanosoma cruzi contain cruzipain.
    Gruppi A; Cerbán FM; Vottero-Cima E
    Acta Trop; 1997 Feb; 63(2-3):141-9. PubMed ID: 9088427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: immunological cross-reactivity of the major cysteinyl proteinase (cruzipain) with a parasite cytosol acidic antigen (FIV).
    Cerban FM; Motran C; Laderach D; Gea S; Gruppi A; Vottero-Cima E
    Acta Trop; 1994 Dec; 58(3-4):337-43. PubMed ID: 7709872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection.
    Cazorla SI; Frank FM; Becker PD; Arnaiz M; Mirkin GA; Corral RS; Guzmán CA; Malchiodi EL
    J Infect Dis; 2010 Jul; 202(1):136-44. PubMed ID: 20497050
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chain CY; Pires Souto DE; Sbaraglini ML; Labriola CA; Daza Millone MA; Ramirez EA; Cisneros JS; Lopez-Albizu C; Scollo K; Kubota LT; Ruiz AM; Vela ME
    ACS Infect Dis; 2019 Nov; 5(11):1813-1819. PubMed ID: 31538468
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase.
    Arnholdt AC; Piuvezam MR; Russo DM; Lima AP; Pedrosa RC; Reed SG; Scharfstein J
    J Immunol; 1993 Sep; 151(6):3171-9. PubMed ID: 7690795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).
    Laderach D; Cerban F; Motran C; Vottero de Cima E; Gea S
    Int J Parasitol; 1996 Nov; 26(11):1249-54. PubMed ID: 9024869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cruzipain, the major cysteine proteinase from the protozoan parasite Trypanosoma cruzi.
    Cazzulo JJ; Stoka V; Turk V
    Biol Chem; 1997 Jan; 378(1):1-10. PubMed ID: 9049059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of monoclonal antibodies against the major cysteine proteinase of Trypanosoma cruzi.
    Gonzalez G; Orn A; Cazzulo JJ; Grönvik KO
    Scand J Immunol; 1994 Oct; 40(4):389-94. PubMed ID: 7939410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease.
    Duschak VG; Riarte A; Segura EL; Laucella SA
    Immunol Lett; 2001 Oct; 78(3):135-42. PubMed ID: 11578687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
    Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
    Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
    Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
    Front Immunol; 2020; 11():1279. PubMed ID: 32695105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of Trypanosoma cruzi cysteine proteinase.
    Arnholdt AC; Scharfstein J
    Res Immunol; 1991 Feb; 142(2):146-51. PubMed ID: 1714087
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of cruzipain, the major cysteine proteinase from Trypanosoma cruzi and its C-terminal extension in biological fluids during experimental infection in mice.
    González G; Sunnemark D; Orn A; Grönvik KO
    Scand J Immunol; 1996 Aug; 44(2):122-8. PubMed ID: 8711424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identity of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi and an antigen (Ag163B6) isolated with a monoclonal antibody.
    Malchiodi EL; Chiaramonte MG; Martínez JA; Zwirner NW; Margni RA; Cazzulo JJ
    Immunol Lett; 1993 Jan; 35(1):59-62. PubMed ID: 8458637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cell responses against the major cysteine proteinase (cruzipain) of Trypanosoma cruzi: role of the multifunctional alpha 2-macroglobulin receptor in antigen presentation by monocytes.
    Morrot A; Strickland DK; Higuchi Mde L; Reis M; Pedrosa R; Scharfstein J
    Int Immunol; 1997 Jun; 9(6):825-34. PubMed ID: 9199965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice.
    Acosta DM; Arnaiz MR; Esteva MI; Barboza M; Stivale D; Orlando UD; Torres S; Laucella SA; Couto AS; Duschak VG
    Int Immunol; 2008 Apr; 20(4):461-70. PubMed ID: 18195050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric synthetic peptides as antigens for detection of antibodies to Trypanosoma cruzi.
    Hernández Marin M; Hernández Spengler I; Ramos Martínez G; Pozo Peña L
    Biochem Biophys Res Commun; 2006 Jan; 339(1):89-92. PubMed ID: 16289376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.
    Thomas MC; Fernández-Villegas A; Carrilero B; Marañón C; Saura D; Noya O; Segovia M; Alarcón de Noya B; Alonso C; López MC
    Clin Vaccine Immunol; 2012 Feb; 19(2):167-73. PubMed ID: 22155766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.